Showing results 1 to 3 of 3
Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)
Final results of a phase I/II dose escalation trial of valtorcitabine in patients with chronic hepatitis B
Proceeding/Conference:Journal of Hepatology
Valtorcitabine provides potent suppression of hepatitis B virus in patients with chronic hepatitis B: Results of a phase I/II clinical trial.
Proceeding/Conference:55th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, USA 29 Oct-2 Nov 2004 (Published in Hepatology)